Argatroban, a thrombin inhibitor, decreased mortality after 10 min of forebrain ischemia in the gerbil

Neuroscience Letters

Volumn 279, Issue 2, 2000, Pages 93-96

  Mima, Tatsuo ^a   Jin, Yong Jian ^a   Hirayama, Teruyoshi ^a   Gulam Mostafa, Mohammed ^a   Mori, Koreaki ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Argatroban; Brain edema; Cerebral blood flow; Forebrain; Gerbil; Survival study; Thrombin; Transient cerebral ischemia

Indexed keywords

ARGATROBAN; HEPARIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN BLOOD FLOW; BRAIN EDEMA; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE SEVERITY; FOREBRAIN; GERBIL; MALE; MORTALITY; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; REPERFUSION;

ANIMALS; ANTITHROMBINS; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; DEATH; GERBILLINAE; ISCHEMIC ATTACK, TRANSIENT; PIPECOLIC ACIDS; PROSENCEPHALON; REGIONAL BLOOD FLOW; TIME FACTORS;

EID: 0033969752     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00959-3     Document Type: Article

References (16)

1. Albers G.W. Antithrombotic agents in cerebral ischemia. Am. J. Cardiol. 75:1995;34B-38B.
2. Catella-Lawson F. Direct thrombin inhibitors in cardiovascular disease. Coron. Artery Dis. 8:1997;105-111.
3. Duval N., Lunven C., O'Brien D.P., Grosset A., O'Connor S.E., Berry C.N. Antithrombotic actions of the thrombin inhibitor, argatroban, in a canine model of coronary cyclic flow: comparison with heparin. Br. J. Pharmacol. 118:1996;727-733.
4. Fitzgerald D.J., Fitzgerald G.A. Role of thrombin and thromboxane A2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activator. Proc. Natl. Acad. Sci. USA. 86:1989;7585-7589.
5. 125I-albumin. Stroke. 16:1985;101-109.
6. Hantgan R.R., Jerome W.G., Hursting M.J. No effect of clot age or thrombolysis on argatroban's inhibition of thrombin. Blood. 92:1998;2064-2074.
7. Hara T., Iwamoto M., Ishihara M., Tomikawa M. Preventive effect of argatroban on ellagic acid-induced cerebral thromboembolism in rats. Haemostasis. 24:1994;351-357.
8. Jang I.K., Brown D.F., Giugliano R.P., Anderson H.V., Losordo D., Nicolau J.C., Dutra O.P., Bazzino O., Viamonte V.M., Norbady R., Liprandi A.S., Massey T.J., Dinsmore R., Schwarz R.P. Jr. A multicenter, randomized study of argatroban versus heparin as adjunct to tissue plasminogen activator (TPA) in acute myocardial infarction: myocardial infarction with novastan and TPA (MINT) study. J. Am. Coll. Cardiol. 33:1999;1879-1885.
9. Kario K., Kodama K., Koide M., Matsuo T. Thrombin inhibition in the acute phase of ischaemic stroke using argatroban. Blood Coagul. Fibrinolysis. 6:1995;423-427.
10. Kawai H., Yuki S., Sugimoto J., Tamao Y. Effects of a thrombin inhibitor, argatroban, on ischemic brain damage in the rat distal middle cerebral artery occlusion model. J. Pharmacol. Exp. Ther. 278:1996;780-785.
11. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 239:1982;57-69.
12. Kirino T., Sano K. Selective vulnerability in the gerbil hippocampus following transient ischemia. Acta Neuropathol. 62:1984;201-208.
13. Kobayashi S., Tazaki Y. Effect of the thrombin inhibitor argatroban in acute cerebral thrombosis. Semin. Thromb. Hemost. 23:1997;531-534.
14. Lin C.S., Polsky K., Nadler J.V., Crain B.J. Selective neocortex and thalamic cell death in the gerbil after transient ischemia. Neuroscience. 35:1990;289-299.
15. Nadler J.V., Evenson D.A. Use of excitatory amino acids to make axon-sparing lesion of hypothalamus. Method Enzymol. 103:1983;393-400.
16. Stummer W., Weber K., Tranmer B., Baethmann A., Kempski O. Reduced mortality and brain damage after locomotor activity in gerbil forebrain ischemia. Stroke. 25:1994;1862-1869.